Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2026-04-07 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
董事会秘书工作细则
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules' and details the duties, appointment, qualifications, training, and responsibilities of the company's board secretary. It references relevant laws and regulations such as the Company Law, Securities Law, and Shenzhen Stock Exchange listing rules. The content is focused on governance practices and internal company rules regarding the board secretary role. There is no financial data, earnings information, or report publication announcement. It is a governance-related document outlining internal rules and procedures for board secretary management. Therefore, the document fits best under Governance Information (CGR). The document length is 4455 characters, which is sufficient for a detailed governance document, not a brief announcement or certification.
2026-04-07 Chinese
募集资金专项存储及使用管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for the storage and use of raised funds by a company, including regulatory references to Chinese securities laws and Shenzhen Stock Exchange rules. It outlines procedures, responsibilities, and compliance requirements related to the use of funds raised through stock issuance. The document is not a financial report, earnings release, or announcement but rather a governance and compliance manual related to capital management. It does not contain financial statements or results but focuses on internal rules and governance practices regarding fundraising and fund usage. Therefore, it fits best under Governance Information (CGR). The document length (8320 characters) and content confirm it is a substantive governance report, not a brief announcement or certification.
2026-04-07 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled '投资者关系管理制度' which translates to 'Investor Relations Management System'. It details the company's policies, principles, organizational structure, responsibilities, and procedures for managing investor relations. It includes sections on communication with investors, information disclosure, investor protection, and compliance with relevant laws and regulations. There are no financial statements, earnings data, or specific report disclosures. The document is a governance-related policy document outlining internal rules and practices for investor relations management. It does not fit categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including investor relations policies.
2026-04-07 Chinese
第四届董事会第五次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the fifth meeting of the fourth board of directors of the company. It details the meeting attendance, the agenda items discussed, voting results, and references to related announcements. The content focuses on board decisions, governance matters, and scheduling of a shareholders' meeting. There are no financial statements, earnings data, or audit information presented. The document is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short (1534 characters), and it is not an announcement of a report publication but a substantive announcement of board decisions.
2026-04-07 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors'. It details the composition, responsibilities, meeting procedures, committees, and governance structure of the company's board. It references company law, securities law, stock exchange listing rules, and the company's articles of association. The content is focused on governance practices, board meeting protocols, and internal rules rather than financial results, audit opinions, or announcements. There is no indication that this is an announcement or a report of a meeting, nor is it a financial report or a regulatory filing of voting results. The document fits the description of Governance Information (CGR) as it details the company's internal rules, board structure, and governance practices.
2026-04-07 Chinese
信息披露制度
Governance Information Classification · 100% confidence The document is titled "信息披露管理制度" (Information Disclosure Management System) for 西藏易明西雅医药科技股份有限公司. It extensively details the company's policies and procedures for information disclosure, including references to laws and regulations such as the Securities Law of China, Shenzhen Stock Exchange Listing Rules, and China Securities Regulatory Commission requirements. The document covers the scope and standards for periodic reports (annual, semi-annual, quarterly), interim reports, temporary reports, board resolutions, shareholder meeting resolutions, and disclosure of transactions. It also discusses the responsibilities of the board, management, and shareholders in disclosure, as well as the timing and content requirements for various disclosures. This document is a governance and compliance manual outlining internal rules and governance practices related to information disclosure. It is not an actual financial report, earnings release, or announcement of voting results. It is a detailed governance document about disclosure policies and procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive governance policy document.
2026-04-07 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.